Drug intelligence / Profile preview

CH-10D7ICG

Development stage
Preclinical
Lead developer
The University of Queensland
Modality
Small Molecules, Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

CH-10D7ICG is a **fluorescent probe** created by chemically conjugating the near-infrared dye **indocyanine green (ICG)** to the monoclonal antibody **10D7**, which specifically targets the CUB-domain-containing protein 1 (CDCP1), a receptor overexpressed on ovarian cancer cells. This agent is developed to enable **tumor-selective fluorescence imaging**, enhancing the visualization of ovarian cancer lesions during surgery. Preclinical studies have shown intravenous administration of CH-10D7ICG allows preferential accumulation in ovarian cancer xenografts, supporting its potential use in **fluorescence-guided surgery for ovarian cancer**[1].

Other names
10D7-ICG
02

Targets

CDCP1 (CUB domain-containing protein 1)

Beyond the preview

Go deeper on CH-10D7ICG.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CH-10D7ICG.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call